MFDS Korea 2025｜Faster Drug Approval with Project Review Teams & 90-Day GMP
When foreign pharmaceutical companies prepare to enter the Korean market, the first barrier is not just language differences. A bigger challenge lies in the constantly changing regulatory environment. If a company is conducting a clinical trial or seeking new drug…
